BC Cancer Foundation - Impact Report 2016 - (Page 6)

research in the Lab PREDICTING RESPONSE TO TREATMENT IDENTIFYING GENETIC MUTATIONS Today, experts recognize more than 40 different types of lymphoid cancers. To bring more effective, personalized therapies to patients, the BC Cancer Agency's Centre for Lymphoid Cancer genomically sequenced 1,000 lymphoid cancers 6 IMPACT REPORT 2016 for treatment failure, which may lead to more effective, life-saving treatments. The study, published in The Lancet Oncology, proved that the test, called m7-FLIPI, can reliably predict patient response to existing treatments. Follicular lymphoma is a subtype of non-Hodgkin lymphoma, and while effective treatments exist, about 20 per cent of patients respond poorly or not at all to current therapies. Identifying the patient whose treatment is likely to fail from the onset We means oncologists can plan alternate, support potentially life-saving treatment 800 cancer researchers at approaches. Philanthropy made the Bc cancer this breakthrough possible. agency. TEST REFINES TREATMENT SELECTION FOR MANTLE CELL LYMPhOMA Dr. David Scott and his team developed a new test for use by clinicians treating patients with mantle cell lymphoma. This subtype of non-hodgkin lymphoma is an aggressive, incurable disease. Patients go through chemotherapy and stem cell transplants and they're still not being cured- overall survival is about five years. The new test, MCL55, is a clinical assay that will provide clinicians with a tool to help determine which patients would respond to different treatments. Top Left Icon and illustrations by ThinkStock this year. This process helps identify mutations that cause cancer on a molecular level. With donor support, Dr. Joseph Connors and Dr. Randy Gascoyne are leading this research, hoping to achieve better results for B.C. patients in the future. BC Cancer Agency researchers developed a test that identifies follicular lymphoma patients at the highest risk

Table of Contents for the Digital Edition of BC Cancer Foundation - Impact Report 2016

BC Cancer Foundation - Impact Report 2016
Contents
Immunotherapy
Research in the Lab
Research in the Clinic
Ride to Conquer Cancer1
Personalized Onco-Genomics
BC Cancer Foundation by the Numbers
Financial Five-Year Summary
Financial Highlights

BC Cancer Foundation - Impact Report 2016

http://www.nxtbook.com/nxtbooks/manifest/bccancer_2018spring
http://www.nxtbook.com/nxtbooks/manifest/bccancer_2017winter
http://www.nxtbook.com/nxtbooks/manifest/bccancer_2017fall
http://www.nxtbook.com/nxtbooks/manifest/bccancer_2017donorreport
http://www.nxtbook.com/nxtbooks/manifest/bccancer_2017spring
http://www.nxtbook.com/nxtbooks/manifest/bccancer_2016winter
http://www.nxtbook.com/nxtbooks/manifest/bccancer_2016fall
http://www.nxtbook.com/nxtbooks/manifest/bccancer_impactreport2016
http://www.nxtbook.com/nxtbooks/manifest/bccancer_2016spring
http://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2015winter
http://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2015fall
http://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2015report
http://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2015spring
http://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2014winter
http://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2014fall
http://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2014report
http://www.nxtbookMEDIA.com